PRICE T ROWE ASSOCIATES INC /MD/ - JUNO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$50,064,000
-1.3%
1,095,263
-3.1%
0.01%
-11.1%
Q3 2017$50,728,000
+123.2%
1,130,805
+48.7%
0.01%
+125.0%
Q2 2017$22,723,000
+33.2%
760,222
-1.1%
0.00%
+33.3%
Q1 2017$17,058,000
+11.6%
768,712
-5.2%
0.00%0.0%
Q4 2016$15,282,000
+2049.4%
810,718
+3321.0%
0.00%
Q3 2016$711,000
-21.6%
23,698
+0.4%
0.00%
Q2 2016$907,000
-87.5%
23,600
-87.6%
0.00%
-100.0%
Q1 2016$7,253,000
+146.4%
190,429
+184.5%
0.00%
+100.0%
Q4 2015$2,943,000
-26.1%
66,929
-31.6%
0.00%0.0%
Q3 2015$3,980,000
-23.9%
97,806
-0.3%
0.00%0.0%
Q2 2015$5,232,00098,1000.00%
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders